Article
MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Cell death & disease - 26 Aug 2021
Deng Xiaochong, Ye Danrong, Hua Kaiyao, Song Hongming, Luo Qifeng, Munankarmy Amik, Liu Diya, Zhou Baian, Zheng Wenfang, Zhou Xiqian, Ji Changle, Wang Xuehui, Yu Yunhe, Fang Lin
Abstract excerpt
The long noncoding RNA called MIR22 host gene (MIR22HG) was previously identified as a tumor suppressor in several cancers. However, the biological function of MIR22HG in breast cancer remains unknown. In this study, we aimed to determine the function and molecular mechanism of MIR22HG in breast cancer progression using transcriptomics and biotechnological techniques. Our results showed that MIR22HG expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
